Skip to main content
. 2022 Sep 23;10:1000415. doi: 10.3389/fpubh.2022.1000415

Table 4.

Distribution of breast cancer synchronous brain metastases cancer-specific mortality and hazard risk associated with various prognostic factors.

Variables Categories Deaths N (%) Univariable Multivariable
HR (95%) p-Value HR (95%) p-Value
Age 807 (100%) 1.013 (1.007, 1.019) <0.001 1.016 (1.010, 1.023) <0.001
Year 2011 167 (20.69%) Ref. Ref.
2012 132 (16.36%) 0.886 (0.704, 1.11) 0.300 - -
2013 172 (21.31%) 0.972 (0.782, 1.207) 0.797 - -
2014 148 (18.34%) 0.996 (0.794, 1.249) 0.970 - -
2015 127 (15.74%) 0.923 (0.727, 1.171) 0.507 - -
2016 61 (7.56%) 0.889 (0.656 1.204) 0.447 - -
Race NHW 493 (61.09%) Ref. Ref.
NHB 165 (20.45%) 1.302 (1.091, 1.553) 0.003 1.153 (0.959, 1.387) 0.131
NHAI/AN 5 (0.62%) 0.790 (0.327, 1.906) 0.599 1.094 (0.449, 2.665) 0.843
NHAPI 55 (6.82%) 0.983 (0.743, 1.299) 0.901 1.071 (0.803, 1.427) 0.642
Hispanic 89 (11.03%) 0.846 (0.675, 1.06) 0.147 0.843 (0.669, 1.063) 0.149
Region Northeast 148 (18.34%) Ref. Ref.
Midwest 75 (9.29%) 1.231 (0.932, 1.625) 0.143 - -
South 233 (28.87%) 1.000 (0.814, 1.229) 0.999 - -
West 351 (43.49%) 0.847 (0.699, 1.026) 0.090 - -
Marital status Married 304 (37.67%) Ref. Ref.
Others 503 (62.33%) 1.418 (1.229, 1.635) 0.001 1.266 (1.090, 1.472) 0.002
Insurance status Insured 536 (66.42%) Ref. Ref.
Others 271 (33.58%) 1.175 (1.015, 1.36) 0.030 1.165 (0.994, 1.365) 0.060
Primary tumor site Central 36 (4.46%) Ref. Ref.
Upper-inner 43 (5.33%) 1.493 (0.958, 2.325) 0.076 - -
Lower-inner 16 (1.98%) 0.679 (0.376, 1.224) 0.197 - -
Upper-outer 149 (18.46%) 1.0994 (0.764, 1.582) 0.610 - -
Lower-outer 31 (3.84%) 1.181 (0.731, 1.910) 0.497 - -
Axillary tail 6 (0.74%) 0.783 (0.330, 1.859) 0.579 - -
Others 526 (65.18%) 1.289 (0.919, 1.806) 0.142 - -
T-Stage 1 82 (10.16%) Ref. Ref.
2 156 (19.33%) 1.191 (0.911, 1.556) 0.202 1.234 (0.942, 1.618) 0.127
3 102 (12.64%) 1.378 (1.030, 1.843) 0.031 1.340 (0.998, 1.801) 0.052
4 287 (35.56%) 1.615 (1.263, 2.064) <0.001 1.536 (1.197, 1.972) 0.001
Others 180 (22.3%) 1.353 (1.042, 1.757) 0.023 1.331 (1.022, 1.733) 0.034
LNPRate 0–20% 19 (2.35%) Ref. Ref.
21–40% 10 (1.24%) 0.779 (0.362, 1.676) 0.522 - -
41–60% 5 (0.62%) 0.771 (0.288, 2.066) 0.605 - -
61–80% 8 (0.99%) 0.965 (0.422, 2.206) 0.933 - -
81–100% 64 (7.93%) 0.999 (0.598, 1.667) 0.995 - -
Unexamined 577 (71.5%) 1.334 (0.844, 2.109) 0.217 - -
Others 124 (15.37%) 1.230 (0.758, 1.993) 0.404 - -
Subtype HR+/HER2– 289 (35.81%) Ref. Ref.
HR+/HER2+ 110 (13.63%) 0.836 (0.670, 1.041) 0.109 0.865 (0.693, 1.081) 0.202
HR–/HER2+ 90 (11.15%) 1.118 (0.883, 1.417) 0.355 1.072 (0.842, 1.364) 0.573
Triple-negative 169 (20.94%) 2.014 (1.659, 2.444) <0.001 2.185 (1.792, 2.665) <0.001
Unknown 149 (18.46%) 1.715 (1.406, 2.092) <0.001 1.777 (1.448, 2.181) <0.001
Bone metastases No 286 (35.44%) Ref. Ref.
Yes 521 (64.56%) 0.952 (0.824, 1.100) 0.507 - -
Liver metastases No 506 (62.7%) Ref. Ref.
Yes 301 (37.3%) 1.480 (1.282, 1.707) <0.001 1.616 (1.389, 1.880) <0.001
Lung metastases No 405 (50.19%) Ref. Ref.
Yes 402 (49.81%) 1.288 (1.122, 1.479) <0.001 1.169 (1.012, 1.350) 0.033
Income* Continuous 807 (100%) 0.403 (0.273, 0.596) <0.001 0.408 (0.271, 0.615) <0.001
Education* Continuous 807 (100%) 1.006 (0.994, 1.018) 0.317 - -

Income*, median household income, increased by per $10 000 annual; Education*, high school education percent, increased by per 10%; NHW, Non-Hispanic White; NHB, Non-Hispanic Black; NHAI/AN, Non-Hispanic American Indian/Alaska Native; NHAPI, Non-Hispanic Asian or Pacific Islander.